The role of the control of “life’s essential 8” for prevention on heart failure and all-cause mortality in patients with hypertension: the Kailuan cohort study
Abstract Background Hypertension can lead to an increased risk of heart failure and death. The life’s essential 8 (LE8) is an eight-factor measure of cardiovascular health recently released by the American Heart Association for use in measuring cardiovascular health. However, evidence on the benefic...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Public Health |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12889-025-22422-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849726440315027456 |
|---|---|
| author | Jing Wang Shuilin Wu Liuxin Li Jing Wu Shiqiu Meng Xueying Qin Xin Chen Shoulin Wu Jie Shi Yanping Bao Feng Wang |
| author_facet | Jing Wang Shuilin Wu Liuxin Li Jing Wu Shiqiu Meng Xueying Qin Xin Chen Shoulin Wu Jie Shi Yanping Bao Feng Wang |
| author_sort | Jing Wang |
| collection | DOAJ |
| description | Abstract Background Hypertension can lead to an increased risk of heart failure and death. The life’s essential 8 (LE8) is an eight-factor measure of cardiovascular health recently released by the American Heart Association for use in measuring cardiovascular health. However, evidence on the beneficial effects and necessity of LE8 control is still lacking, especially for hypertension. Methods The study population was drawn from the Kailuan cohort, hypertensive population at baseline with the non-hypertensive population matched 1:1 according to age and sex were involved in this analysis. The cut off value for each factor in LE8 was 50 (≥ 50 as controlled, < 50 as uncontrolled). The primary outcomes involved heart failure and all-cause mortality. Cox proportional risk regression models were used to analyze the relationship between the degree of LE8 control and the risk of heart failure and all-cause mortality among hypertensive participants. Hazard ratio (HR) and 95% confidence interval (95% CI) were calculated. Results A baseline population of 69,032 Kailuan cohort with a mean age of 53.08 years (SD 10.59) was included in the study. During a mean follow-up period of 13.17 years (SD 2.57), 1308 (3.8%) heart failures and 5391 (15.6%) deaths occurred among hypertensive patients. In the hypertensive population, there was a negative dose response between the degree of LE8 control and the risk of heart failure or death (P for trend < 0.001). Compared with the group with the control less than or equal to 2 risk factors of LE8, the group with 6 or more risk factors of control had a 55% lower risk of heart failure (HR 0.45, 95% CI 0.26–0.77; P < 0.05) and a 31% lower risk of death (HR 0.69, 95% CI 0.50–0.93; P < 0.05). Compared with the non-hypertensive population, the risk of heart failure and death decreased with increasing of the number of risk factor controlled in LE8, down to a minimum of 1.27-fold (HR 1.27, 95%CI 1.13–1.42; P < 0.05) and 1.25-fold (HR 1.25, 95%CI 1.19–1.32; P < 0.05), respectively. In addition, the association between hypertension and heart failure or mortality was higher in participants aged < 60 years compared with older individuals (P for interaction < 0.05). Conclusions Enhanced control of LE8 is significantly associated with a reduced risk of heart failure and mortality in hypertensive patients, as well as a decreased likelihood of hypertension-related heart failure or mortality. |
| format | Article |
| id | doaj-art-0bbe50b08b894b9dbede9e66c6a71284 |
| institution | DOAJ |
| issn | 1471-2458 |
| language | English |
| publishDate | 2025-04-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Public Health |
| spelling | doaj-art-0bbe50b08b894b9dbede9e66c6a712842025-08-20T03:10:10ZengBMCBMC Public Health1471-24582025-04-0125111110.1186/s12889-025-22422-yThe role of the control of “life’s essential 8” for prevention on heart failure and all-cause mortality in patients with hypertension: the Kailuan cohort studyJing Wang0Shuilin Wu1Liuxin Li2Jing Wu3Shiqiu Meng4Xueying Qin5Xin Chen6Shoulin Wu7Jie Shi8Yanping Bao9Feng Wang10Institute of Advanced Clinical Medicine, Peking UniversitySchool of Public Health, Peking UniversityHealth Care Center, Kailuan Medical GroupChinese Center for Health EducationSchool of Public Health, Peking UniversityNational Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking UniversitySchool of Public Health, Peking UniversityHealth Care Center, Kailuan Medical GroupNational Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking UniversityNational Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking UniversityChinese Center for Health EducationAbstract Background Hypertension can lead to an increased risk of heart failure and death. The life’s essential 8 (LE8) is an eight-factor measure of cardiovascular health recently released by the American Heart Association for use in measuring cardiovascular health. However, evidence on the beneficial effects and necessity of LE8 control is still lacking, especially for hypertension. Methods The study population was drawn from the Kailuan cohort, hypertensive population at baseline with the non-hypertensive population matched 1:1 according to age and sex were involved in this analysis. The cut off value for each factor in LE8 was 50 (≥ 50 as controlled, < 50 as uncontrolled). The primary outcomes involved heart failure and all-cause mortality. Cox proportional risk regression models were used to analyze the relationship between the degree of LE8 control and the risk of heart failure and all-cause mortality among hypertensive participants. Hazard ratio (HR) and 95% confidence interval (95% CI) were calculated. Results A baseline population of 69,032 Kailuan cohort with a mean age of 53.08 years (SD 10.59) was included in the study. During a mean follow-up period of 13.17 years (SD 2.57), 1308 (3.8%) heart failures and 5391 (15.6%) deaths occurred among hypertensive patients. In the hypertensive population, there was a negative dose response between the degree of LE8 control and the risk of heart failure or death (P for trend < 0.001). Compared with the group with the control less than or equal to 2 risk factors of LE8, the group with 6 or more risk factors of control had a 55% lower risk of heart failure (HR 0.45, 95% CI 0.26–0.77; P < 0.05) and a 31% lower risk of death (HR 0.69, 95% CI 0.50–0.93; P < 0.05). Compared with the non-hypertensive population, the risk of heart failure and death decreased with increasing of the number of risk factor controlled in LE8, down to a minimum of 1.27-fold (HR 1.27, 95%CI 1.13–1.42; P < 0.05) and 1.25-fold (HR 1.25, 95%CI 1.19–1.32; P < 0.05), respectively. In addition, the association between hypertension and heart failure or mortality was higher in participants aged < 60 years compared with older individuals (P for interaction < 0.05). Conclusions Enhanced control of LE8 is significantly associated with a reduced risk of heart failure and mortality in hypertensive patients, as well as a decreased likelihood of hypertension-related heart failure or mortality.https://doi.org/10.1186/s12889-025-22422-yLife’s essential 8Heart failureAll-cause mortalityHypertensionKailuan study |
| spellingShingle | Jing Wang Shuilin Wu Liuxin Li Jing Wu Shiqiu Meng Xueying Qin Xin Chen Shoulin Wu Jie Shi Yanping Bao Feng Wang The role of the control of “life’s essential 8” for prevention on heart failure and all-cause mortality in patients with hypertension: the Kailuan cohort study BMC Public Health Life’s essential 8 Heart failure All-cause mortality Hypertension Kailuan study |
| title | The role of the control of “life’s essential 8” for prevention on heart failure and all-cause mortality in patients with hypertension: the Kailuan cohort study |
| title_full | The role of the control of “life’s essential 8” for prevention on heart failure and all-cause mortality in patients with hypertension: the Kailuan cohort study |
| title_fullStr | The role of the control of “life’s essential 8” for prevention on heart failure and all-cause mortality in patients with hypertension: the Kailuan cohort study |
| title_full_unstemmed | The role of the control of “life’s essential 8” for prevention on heart failure and all-cause mortality in patients with hypertension: the Kailuan cohort study |
| title_short | The role of the control of “life’s essential 8” for prevention on heart failure and all-cause mortality in patients with hypertension: the Kailuan cohort study |
| title_sort | role of the control of life s essential 8 for prevention on heart failure and all cause mortality in patients with hypertension the kailuan cohort study |
| topic | Life’s essential 8 Heart failure All-cause mortality Hypertension Kailuan study |
| url | https://doi.org/10.1186/s12889-025-22422-y |
| work_keys_str_mv | AT jingwang theroleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT shuilinwu theroleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT liuxinli theroleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT jingwu theroleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT shiqiumeng theroleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT xueyingqin theroleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT xinchen theroleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT shoulinwu theroleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT jieshi theroleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT yanpingbao theroleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT fengwang theroleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT jingwang roleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT shuilinwu roleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT liuxinli roleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT jingwu roleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT shiqiumeng roleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT xueyingqin roleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT xinchen roleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT shoulinwu roleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT jieshi roleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT yanpingbao roleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy AT fengwang roleofthecontroloflifesessential8forpreventiononheartfailureandallcausemortalityinpatientswithhypertensionthekailuancohortstudy |